{"database": "openregs", "table": "federal_register", "rows": [["2011-31613", "New Animal Drugs for Use in Animal Feeds; Tilmicosin", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, a division of Eli Lilly & Co. The supplemental NADA provides for use of tilmicosin Type C medicated feeds by veterinary feed directive for the control of bovine respiratory disease in groups of beef and nonlactating dairy cattle.", "2011-12-09", 2011, 12, "https://www.federalregister.gov/documents/2011/12/09/2011-31613/new-animal-drugs-for-use-in-animal-feeds-tilmicosin", "https://www.govinfo.gov/content/pkg/FR-2011-12-09/pdf/2011-31613.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, a division of Eli Lilly & Co. The supplemental NADA provides for use...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2011-31613"], "units": {}, "query_ms": 0.41165086440742016, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}